Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00524680 · ClinicalTrials.gov registry record · Phase 2
Vitamin D in Treating Patients With Prostate Cancer
A Phase 2 study, sponsored by Roswell Park Cancer Institute.
- Completed
- Registry status
- Phase 2
- Development phase
- 148
- Enrollment target
NCT00524680 is a Phase 2 study that has completed, run by Roswell Park Cancer Institute. The registered enrollment target is 148 participants.
The verdict
NCT00524680, a Phase 2 study, has completed, sponsored by Roswell Park Cancer Institute.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 148 participants
- Enrollment target
Study Summary
RATIONALE: Vitamin D may be effective in treating patients with prostate cancer. PURPOSE: This randomized phase II trial is studying how well 4 different doses of vitamin D works in treating patients with prostate cancer.
Interventions
- DIETARY_SUPPLEMENT cholecalciferol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 148 participants |
| Start Date | 2007-06 |
| Est. Completion | 2013-03 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00524680
The ClinicalTrials.gov registry entry for NCT00524680 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 148 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Roswell Park Cancer Institute, which has 365 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which cholecalciferol is the first listed.
NCT00524680 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00524680 about?
NCT00524680 is a clinical study titled "Vitamin D in Treating Patients With Prostate Cancer". RATIONALE: Vitamin D may be effective in treating patients with prostate cancer. PURPOSE: This randomized phase II trial is studying how well 4 different doses of vitamin D works in treating patients with prostate cancer.
What is the current status of trial NCT00524680?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 148 participants. The study started on 2007-06. Estimated completion is 2013-03.
What interventions are being tested in trial NCT00524680?
The interventions under investigation include: cholecalciferol (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00524680?
This trial is sponsored by Roswell Park Cancer Institute, which has 365 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.